[1]
|
J. A. Jaffe and P. L. Kimmel, “Chronic Nephropathies of Cocaine and Heroin Abuse: A Critical Review,” Clinical Journal of the American Society of Nephrology, Vol. 1, No. 4, 2006, pp. 655-667. doi:10.2215/CJN.00300106
|
[2]
|
S. Aslibekyan, E. B. Levitan and M. A. Mittleman, “Prevalent Cocaine Use and Myocardial Infarction,” American Journal of Cardiology, Vol. 102, No. 8, 2008, pp. 966-969. doi:10.1016/j.amjcard.2008.06.016
|
[3]
|
K. D. Meyer and L. Zhang, “Shortand Long-Term Adverse Effects of Cocaine Abuse during Pregnancy on the Heart Development,” Therapeutic Advances in Cardiovascular Disease, Vol. 3, No. 1, 2009, pp. 7-16.
doi:10.1177/1753944708099877
|
[4]
|
R. J. Devlin and J. A. Henry, “Clinical Review: Major Consequences of Illicit Drug Consumption,” Critical Care, Vol. 12, No. 1, 2008, p. 202. doi:10.1186/cc6166
|
[5]
|
C. S. Restrepo, C. A. Rojas, S. Martinez, R. Riascos, A. Marmol-Velez, J. Carrillo, et al., “Cardiovascular Complications of Cocaine: Imaging Findings,” Emergency Radiology, Vol. 16, No. 1, 2009, pp. 11-19.
doi:10.1007/s10140-008-0762-x
|
[6]
|
K. B. Keller and L. Lemberg, “The Cocaine-Abused Heart,” American Journal of Critical Care, Vol. 12, No. 6, 2003, pp. 562-566.
|
[7]
|
E. Y. Plotnikov, A. A. Chupyrkina, I. B. Pevzner, N. K. Isaev and D. B. Zorov, “Myoglobin Causes Oxidative Stress, Increase of No Production and Dysfunction of Kidney’s Mitochondria,” Biochimica et Biophysica Acta, Vol. 1792, No. 8, 2009, pp. 796-803.
doi:10.1016/j.bbadis.2009.06.005
|
[8]
|
R. A. Kloner and S. H. Rezkalla, “Cocaine and the Heart,” The New England Journal of Medicine, Vol. 348, No. 6, 2003, pp. 487-488. doi:10.1056/NEJMp020174
|
[9]
|
SAMSHA, “Results from the 2008 National Survey on Drug Use and Health: National Findings,” Office of Applied Studies, Rockville, 2009
|
[10]
|
B. Ostadal, I. Netuka, J. Maly, J. Besik and I. Ostadalova, “Gender Differences in Cardiac Ischemic Injury and Protection—Experimental Aspects,” Experimental Biology and Medicine, Vol. 234, No. 9, 2009, pp. 1011-1019.
doi:10.3181/0812-MR-362
|
[11]
|
A. A. Quyyumi, “Women and Ischemic Heart Disease: Pathophysiologic Implications from the Women’s Ischemia Syndrome Evaluation (WISE) Study and Future Research Steps,” Journal of the American College of Cardiology, Vol. 47, No. 3S, 2006, pp. S66-S71.
doi:10.1016/j.jacc.2004.11.075
|
[12]
|
R. A. Kloner, S. Hale, K. Alker and S. Rezkalla, “The Effects of Acute and Chronic Cocaine Use on the Heart,” Circulation, Vol. 85, No. 2, 1992, pp. 407-419.
doi:10.1161/01.CIR.85.2.407
|
[13]
|
H. F. Poon, L. Abdullah, M. A. Mullan, M. J. Mullan and F. C. Crawford, “Cocaine-Induced Oxidative Stress Precedes Cell Death in Human Neuronal Progenitor Cells,” Neurochemistry International, Vol. 50, No. 1, 2007, pp. 69-73. doi:10.1016/j.neuint.2006.06.012
|
[14]
|
I. S. Richards, “Health Effects of Illicit Cocaine Use,” Pulmonary and Critical Care Update American College of Chest Physicians, Vol. 7, No. 2, 1991, pp. 1-7.
|
[15]
|
J. R. Richards, “Rhabdomyolysis and Drugs of Abuse,” Journal of Emergency Medicine, Vol. 19, No. 1, 2000, pp. 51-56. doi:10.1016/S0736-4679(00)00180-3
|
[16]
|
T. Pisitkun, R. Johnstone and M. A. Knepper, “Discovery of Urinary Biomarkers,” Molecular & Cellular Proteomics, Vol. 5, No. 10, 2006, pp. 1760-1771.
doi:10.1074/mcp.R600004-MCP200
|
[17]
|
D. Seger, “Cocaine, Metamfetamine, and MDMA Abuse: The Role and Clinical Importance of Neuroadaptation,” Clinical Toxicology (Philadelphia), Vol. 48, No. 7, 2010, pp. 695-708. doi:10.3109/15563650.2010.516263
|
[18]
|
G. Silvestrelli, F. Corea, S. Micheli and A. Lanari, “Clinical Pharmacology and Vascular Risk,” Open Neurology Journal, Vol. 4, 2010, pp. 64-72.
|
[19]
|
S. B. Karch, “Karch’s Pathology of Drug Abuse,” 4th Edition, CRC/Taylor & Francis, Boca Raton, 2009.
|
[20]
|
A. I. Qureshi, M. F. Suri, L. R. Guterman and L. N. Hopkins, “Cocaine Use and the Likelihood of Nonfatal Myocardial Infarction and Stroke: Data from the Third National Health and Nutrition Examination Survey,” Circulation, Vol. 103, No. 4, 2001, pp. 502-506.
doi:10.1161/01.CIR.103.4.502
|
[21]
|
P. M. Johnson and P. J. Kenny, “Dopamine D2 Receptors in Addiction-Like Reward Dysfunction and Compulsive Eating in Obese Rats,” Nature Neuroscience, Vol. 13, No. 5, 2010, pp. 635-641. doi:10.1038/nn.2519
|
[22]
|
C. W. Callaway and R. F. Clark, “Hyperthermia in Psychostimulant Overdose,” Annals of Emergency Medicine, Vol. 24, No. 1, 1994, pp. 68-76.
doi:10.1016/S0196-0644(94)70165-2
|
[23]
|
D. Roth, F. J. Alarcon, J. A. Fernandez, R. A. Preston and J. J. Bourgoignie, “Acute Rhabdomyolysis Associated with Cocaine Intoxication,” The New England Journal of Medicine, Vol. 319, No. 11, 1988, pp. 673-677.
doi:10.1056/NEJM198809153191103
|
[24]
|
R. J. de Winter, R. W. Koster, A. Sturk and G. T. Sanders, “Value of Myoglobin, Troponin T, and CK-MB Mass in Ruling Out an Acute Myocardial Infarction in the Emergency Room,” Circulation, Vol. 92, No. 12, 1995, pp. 3401-3407. doi:10.1161/01.CIR.92.12.3401
|
[25]
|
M. P. Hudson, R. H. Christenson, L. K. Newby, A. L. Kaplan and E. M. Ohman, “Cardiac Markers: Point of Care Testing,” Clinica Chimica Acta, Vol. 284, No. 2, 1999, pp. 223-237. doi:10.1016/S0009-8981(99)00083-2
|